Patent · US Active

Transdermal therapeutic system containing asenapine and polysiloxane or polyisobutylene

US11337932B2 · kind B2 · utility

3Cited by

90References

19Claims

0Family size

Assignee

LTS Lohmann Therapie-Systeme AG · DE

Inventors

Patrick Mohr · Mims, US
René RIETSCHER · Neuwied, DE
René Eifler · Koblenz, DE
Olga BOURQUAIN · Dürrholz, DE

Key dates

Filing date	Dec 19, 2017
Grant date	May 24, 2022
Priority date	—
Expiry date	Mar 2, 2038

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P25/24
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to a transdermal therapeutic system (TTS) for the transdermal administration of asenapine comprising a self-adhesive layer structure comprising a therapeutically effective amount of asenapine, said self-adhesive layer structure comprising: A) a backing layer; B) an asenapine-containing layer comprising: 1. asenapine in the form of the free base; and 2. a polymer selected from the group consisting of polysiloxanes and polyisobutylenes in an amount of more than 50% by weight based on the total weight of the asenapine-containing layer; and C) optionally an additional skin contact layer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.